Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The Locations section now lists District of Columbia, Maryland, and Pennsylvania as study sites, with Revision: v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T17:21:54.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Added related topic tags: Ovarian cancer and MedlinePlus Genetics to the study page. These changes are metadata and do not alter the trial details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-09T01:18:29.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Removed the 'Ovarian Cancer' topic tag and related topics such as MedlinePlus Genetics from the study page. This affects the page’s categorization and discoverability for users searching by disease.
    Difference
    0.2%
    Check dated 2025-12-01T23:27:30.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.2.0 to v3.3.2 with no observable changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T20:56:19.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice banner from the page.
    Difference
    0.4%
    Check dated 2025-11-17T18:15:56.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the Study Details page content appears unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T13:05:47.000Z thumbnail image

Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.